ClinicalTrials.gg
Not yet recruitingNCT07794176Updated Aug 31, 2026

Comparison of Shockwave Therapy and Apuncture for Chronic Pelvic Pain

An interventional study of Low-intensity Extracorporeal Shockwave Therapy and Acupuncture in Chronic Pain Syndromes, sponsored by Dalin Tzu Chi General Hospital. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Dalin Tzu Chi General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Comparison of Shockwave Therapy (LiESWT) and Acupuncture for Pelvic Floor Myofascial Pain in Postpartum Women

Read the detailed description

Comparison of Low-intensity Extracorporeal Shockwave Therapy (LiESWT) and Acupuncture for Pelvic Floor Myofascial Pain in Postpartum Women

02

Conditions studied

  • Chronic Pain Syndromes

Browse trials for

03

In context

Chronic Pain

3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 2,388 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Dalin Tzu Chi General Hospital is the lead sponsor of 37 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Postpartum 2 weeks
  • Complaining of pelvic floor pain
  • Confirmed with a trigger point by an obstetrician and gynecologist
  • Willing to sign the form

Exclusion criteria

Exclusion Criteria:

  • Postpartum infection
  • Coagulation abnormalities
  • Cardiac pacemaker
  • History of gynecological cancer
  • Concurrently receiving other treatments
  • Long-term use of or muscle relaxants
  • Deemed unsuitable to participate in the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Low-intensity Extracorporeal Shockwave Therapy

    Device: Low-intensity Extracorporeal Shockwave Therapy

  • Active comparator
    Acupuncture

    Device: Acupuncture

Interventions

  • DeviceLow-intensity Extracorporeal Shockwave Therapy

    Patient receive Low-intensity Extracorporeal Shockwave Therapy targeting specific acupoints for chronic pelvic pain management.

  • DeviceAcupuncture

    Patient receive traditional Chinese acupunture treatment targeting specific acupoints for chronic pain management.

06

What researchers measure

Primary outcomes

  1. Change in Pelvic Floor Muscle Pain Score Measured by Numerical Rating Scale (NRS)

    The change in Numerical Rating Scale (NRS) score for pelvic floor myofascial pain from baseline (T0) to post-treatment and follow-up periods.

    Time frame: Baseline (T0), T1 (within 1 week after the end of the treatment course), and T2 (1 month after the end of the treatment course)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07794176
Lead sponsor
Dalin Tzu Chi General Hospital
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
May 31, 2029 (estimated)
Completion
Sep 30, 2029 (estimated)
Last update
Aug 31, 2026

Study contacts

Meng Hsuan Chu
Contact
piggyfunny0001132@gmail.com
+886 0934323623
Chun Shuo Hsu
Contact
d850092@gmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion